ICD-10-CM Billable Code

M11.041

Hydroxyapatite deposition disease, right hand

Clinical Classification Guidelines

Medical Intelligence & Overview

Hydroxyapatite deposition disease is a condition characterized by the abnormal accumulation of calcium phosphate crystals, known as hydroxyapatite, within the soft tissues of the body. When these deposits occur in the joints or soft tissues of the hand, it can lead to pain, inflammation, and movement difficulties. Specifically, the ICD-10 code M11.041 refers to this condition affecting the right hand. Although it can affect various parts of the body, when localized to the hand, it is often associated with repetitive strain or degenerative changes. Recognizing the symptoms and understanding the causes can help manage this condition effectively.

Causes & Symptoms

Clinical Causes: Repeated mechanical trauma or overuse of the hand Degenerative joint diseases, such as osteoarthritis Chronic inflammation or injury to the soft tissues Metabolic disorders that alter calcium and phosphate balance Genetic predisposition to abnormal mineralization

Key Symptoms: Localized pain in the affected area of the hand Swelling and tenderness around the joints or soft tissues Limited range of motion or stiffness in the fingers or hand Visible or palpable lumps or nodules near the joints Redness or warmth over the affected area Recurring flare-ups of pain and inflammation

Diagnostic & Treatment

Diagnosis Path: The diagnosis of hydroxyapatite deposition disease is typically based on a combination of clinical examination and imaging studies. Imaging techniques such as ultrasound, X-rays, or magnetic resonance imaging (MRI) can reveal the presence of calcific deposits in the soft tissues or joints. Sometimes, aspiration of joint fluid may be performed to analyze the crystals under a microscope, confirming the diagnosis. A thorough patient history and physical assessment help differentiate this condition from other inflammatory or degenerative hand disorders.

Treatment Protocols: Treatment strategies focus on alleviating symptoms, reducing inflammation, and preventing further deposits. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain and swelling - Physical therapy to improve hand mobility and strength - Rest and activity modification to reduce stress on the affected tissues - Corticosteroid injections to control severe inflammation - Extracorporeal shock wave therapy as an alternative non-invasive option - Surgical removal of calcific deposits in persistent or severe cases Managing underlying metabolic conditions and following a healthcare provider’s recommendations can also aid in preventing recurrence. Regular monitoring and supportive care are essential components of long-term management.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.041 a billable ICD-10 code?
Yes, M11.041 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.041?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, right hand and any associated comorbidities for accurate reporting.

Cite this Clinical Reference